Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Prognostic Model of Survival of Patients With Hepatocarcinoma and Sarcopenia Treated With Systemic Therapy

Authors not listed

IRCCS Azienda Ospedaliero-Universitaria di Bologna · 2022

Abstract

This is a multi-center, retrospective observational study in patients with liver cancer (HCC) to assess the impact of sarcopenia (muscle loss) on the prognosis, duration, and tolerance of systemic treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Anonymous. (2022). Prognostic Model of Survival of Patients With Hepatocarcinoma and Sarcopenia Treated With Systemic Therapy. <em>IRCCS Azienda Ospedaliero-Universitaria di Bologna</em>. https://clinicaltrials.gov/study/NCT06805552
Vancouver
Anonymous. Prognostic Model of Survival of Patients With Hepatocarcinoma and Sarcopenia Treated With Systemic Therapy. IRCCS Azienda Ospedaliero-Universitaria di Bologna. 2022.
BibTeX
@misc{anon2022Progno, title = {Prognostic Model of Survival of Patients With Hepatocarcinoma and Sarcopenia Treated With Systemic Therapy}, author = {Anonymous}, journal = {IRCCS Azienda Ospedaliero-Universitaria di Bologna}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings